PL365701A1 - Zastosowanie związków karbaminianowych do zapobiegania lub leczenia bólu neuropatycznego i związanego z bólem gromadnego i migrenowego bólu głowy - Google Patents

Zastosowanie związków karbaminianowych do zapobiegania lub leczenia bólu neuropatycznego i związanego z bólem gromadnego i migrenowego bólu głowy

Info

Publication number: PL365701A1
Authority: PL; Poland
Prior art keywords: pain; cluster; preventing; migraine headache; treating neuropathic
Prior art date: 2000-07-21

Application number

PL01365701A

Other languages

English (en)

Inventor

Ellen E. Codd

Richard P. Shank

Katherine E. Rogers

Carlos R. Plata-Salaman

Boyu Zhao

Original Assignee

Ortho-Mcneil Pharmaceutical, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-21

Filing date

2001-07-16

Publication date

2005-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL365701(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-07-16 Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.

2005-01-10 Publication of PL365701A1 publication Critical patent/PL365701A1/pl

Links

208000006561 Cluster Headache Diseases 0.000 title abstract 2
208000019695 Migraine disease Diseases 0.000 title abstract 2
208000002193 Pain Diseases 0.000 title abstract 2
208000018912 cluster headache syndrome Diseases 0.000 title abstract 2
206010027599 migraine Diseases 0.000 title abstract 2
208000004296 neuralgia Diseases 0.000 title abstract 2
208000021722 neuropathic pain Diseases 0.000 title abstract 2
150000004657 carbamic acid derivatives Chemical class 0.000 title 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical group 0.000 abstract 1
229910052740 iodine Inorganic materials 0.000 abstract 1
239000011630 iodine Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL01365701A 2000-07-21 2001-07-16 Zastosowanie związków karbaminianowych do zapobiegania lub leczenia bólu neuropatycznego i związanego z bólem gromadnego i migrenowego bólu głowy PL365701A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US21965700P	2000-07-21	2000-07-21

Publications (1)

Publication Number	Publication Date
PL365701A1 true PL365701A1 (pl)	2005-01-10

Family

ID=22820176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01365701A PL365701A1 (pl)	2000-07-21	2001-07-16	Zastosowanie związków karbaminianowych do zapobiegania lub leczenia bólu neuropatycznego i związanego z bólem gromadnego i migrenowego bólu głowy

Country Status (28)

Country	Link
US (4)	US20020107283A1 (pl)
EP (1)	EP1305082B1 (pl)
JP (1)	JP5271473B2 (pl)
KR (1)	KR100792814B1 (pl)
CN (1)	CN1250213C (pl)
AT (1)	ATE267629T1 (pl)
AU (2)	AU7349301A (pl)
BG (1)	BG107529A (pl)
BR (1)	BR0112713A (pl)
CA (1)	CA2416819C (pl)
CZ (1)	CZ2003445A3 (pl)
DE (1)	DE60103546T2 (pl)
DK (1)	DK1305082T3 (pl)
EA (1)	EA005648B1 (pl)
ES (1)	ES2221651T3 (pl)
HU (1)	HUP0302940A3 (pl)
IL (2)	IL154052A0 (pl)
MX (1)	MXPA03000619A (pl)
MY (1)	MY127317A (pl)
NO (1)	NO330055B1 (pl)
NZ (1)	NZ523851A (pl)
PL (1)	PL365701A1 (pl)
PT (1)	PT1305082E (pl)
SK (1)	SK1962003A3 (pl)
TR (1)	TR200401511T4 (pl)
UA (1)	UA74195C2 (pl)
WO (1)	WO2002007822A2 (pl)
ZA (1)	ZA200301403B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA03007721A (es)	2001-02-27	2004-11-12	Johnson & Johnson	Compuesto de carbamato para su uso en el tratamiento del dolor.
WO2003007934A1 (en)	2001-07-16	2003-01-30	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
RU2299729C2 (ru) *	2001-07-16	2007-05-27	Орто-Макнейл Фармасьютикал, Инк.	Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью
US20040087642A1 (en) *	2002-10-24	2004-05-06	Zeldis Jerome B.	Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
US7323443B2 (en) *	2002-12-12	2008-01-29	Agennix Inc.	Lactoferrin in the reduction of pain
WO2006047744A2 (en) *	2004-10-26	2006-05-04	Agennix Incorporated	Compositions of lactoferrin related peptides and uses thereof
CN101146527A (zh) *	2005-01-20	2008-03-19	詹森药业有限公司	Qt间期控制的方法
NZ570805A (en)	2006-03-30	2011-10-28	Glaxosmithkline Biolog Sa	Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
EA200970368A1 (ru) *	2006-10-10	2009-10-30	Янссен Фармацевтика Нв	Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) *	2013-08-22	2015-02-26	Sucampo Ag	Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3278380A (en) *	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en)	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
HU191549B (en) *	1984-04-11	1987-03-30	Richter Gedeon Vegyeszet	Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) *	1988-12-27	1989-09-19	Hoechst-Roussel Pharmaceuticals, Inc.	N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) *	1995-09-05	1995-11-08	Wellcome Found	Pharmacologically active compound
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
KR20010013435A (ko) *	1997-06-05	2001-02-26	고든 라이트	5-나프탈렌-1-일-1,3-디옥산 유도체, 제조 및 치료에의 이용
RS50676B (sr) *	2001-02-27	2010-06-30	Ortho-Mcneil Pharmaceutical Inc.	Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
DK1401424T3 (da) *	2001-02-27	2007-02-26	Ortho Mcneil Pharm Inc	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser
HUP0303243A3 (en) *	2001-02-27	2012-07-30	Ortho Mcneil Pharm Inc	Carbamate compounds for use in preventing and treating bipolar disorder

2001
- 2001-07-16 PL PL01365701A patent/PL365701A1/pl not_active Application Discontinuation
- 2001-07-16 IL IL15405201A patent/IL154052A0/xx unknown
- 2001-07-16 NZ NZ523851A patent/NZ523851A/en unknown
- 2001-07-16 US US09/906,251 patent/US20020107283A1/en not_active Abandoned
- 2001-07-16 BR BR0112713-6A patent/BR0112713A/pt not_active Application Discontinuation
- 2001-07-16 EP EP01952773A patent/EP1305082B1/en not_active Expired - Lifetime
- 2001-07-16 PT PT01952773T patent/PT1305082E/pt unknown
- 2001-07-16 MX MXPA03000619A patent/MXPA03000619A/es active IP Right Grant
- 2001-07-16 WO PCT/US2001/022322 patent/WO2002007822A2/en not_active Ceased
- 2001-07-16 CA CA2416819A patent/CA2416819C/en not_active Expired - Fee Related
- 2001-07-16 CN CNB01815798XA patent/CN1250213C/zh not_active Expired - Fee Related
- 2001-07-16 ES ES01952773T patent/ES2221651T3/es not_active Expired - Lifetime
- 2001-07-16 UA UA2003010559A patent/UA74195C2/uk unknown
- 2001-07-16 AT AT01952773T patent/ATE267629T1/de not_active IP Right Cessation
- 2001-07-16 AU AU7349301A patent/AU7349301A/xx active Pending
- 2001-07-16 JP JP2002513552A patent/JP5271473B2/ja not_active Expired - Lifetime
- 2001-07-16 SK SK196-2003A patent/SK1962003A3/sk unknown
- 2001-07-16 AU AU2001273493A patent/AU2001273493B2/en not_active Ceased
- 2001-07-16 CZ CZ2003445A patent/CZ2003445A3/cs unknown
- 2001-07-16 EA EA200300042A patent/EA005648B1/ru not_active IP Right Cessation
- 2001-07-16 KR KR1020037000914A patent/KR100792814B1/ko not_active Expired - Lifetime
- 2001-07-16 HU HU0302940A patent/HUP0302940A3/hu unknown
- 2001-07-16 DK DK01952773T patent/DK1305082T3/da active
- 2001-07-16 DE DE60103546T patent/DE60103546T2/de not_active Expired - Lifetime
- 2001-07-16 TR TR2004/01511T patent/TR200401511T4/xx unknown
- 2001-07-20 MY MYPI20013443 patent/MY127317A/en unknown
2003
- 2003-01-20 IL IL154052A patent/IL154052A/en unknown
- 2003-01-20 NO NO20030299A patent/NO330055B1/no not_active IP Right Cessation
- 2003-02-05 BG BG107529A patent/BG107529A/bg unknown
- 2003-02-20 ZA ZA200301403A patent/ZA200301403B/en unknown
2004
- 2004-06-15 US US10/868,633 patent/US20040266866A1/en not_active Abandoned
2005
- 2005-02-18 US US11/194,876 patent/US20060183795A1/en not_active Abandoned
2009
- 2009-07-20 US US12/505,765 patent/US20090281179A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200301403B (en)	2004-06-15
NO330055B1 (no)	2011-02-14
WO2002007822A2 (en)	2002-01-31
US20040266866A1 (en)	2004-12-30
EA005648B1 (ru)	2005-04-28
US20090281179A1 (en)	2009-11-12
IL154052A0 (en)	2003-07-31
HUP0302940A3 (en)	2012-02-28
US20020107283A1 (en)	2002-08-08
WO2002007822A3 (en)	2002-05-30
CZ2003445A3 (cs)	2004-08-18
JP2004504362A (ja)	2004-02-12
CN1458853A (zh)	2003-11-26
TR200401511T4 (tr)	2004-08-23
BG107529A (bg)	2003-09-30
HUP0302940A2 (hu)	2003-12-29
IL154052A (en)	2008-07-08
DK1305082T3 (da)	2004-09-13
AU2001273493B2 (en)	2005-08-11
JP5271473B2 (ja)	2013-08-21
ES2221651T3 (es)	2005-01-01
NO20030299D0 (no)	2003-01-20
EP1305082B1 (en)	2004-05-26
CA2416819A1 (en)	2002-01-31
CA2416819C (en)	2011-03-22
SK1962003A3 (en)	2004-08-03
EA200300042A1 (ru)	2003-06-26
ATE267629T1 (de)	2004-06-15
PT1305082E (pt)	2004-09-30
MXPA03000619A (es)	2004-07-30
AU7349301A (en)	2002-02-05
CN1250213C (zh)	2006-04-12
MY127317A (en)	2006-11-30
BR0112713A (pt)	2003-07-22
DE60103546D1 (de)	2004-07-01
EP1305082A2 (en)	2003-05-02
NO20030299L (no)	2003-03-12
DE60103546T2 (de)	2005-06-09
UA74195C2 (uk)	2005-11-15
KR100792814B1 (ko)	2008-01-14
KR20030022300A (ko)	2003-03-15
NZ523851A (en)	2004-09-24
US20060183795A1 (en)	2006-08-17

Legal Events

Date	Code	Title	Description
2012-08-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
YU67703A (sh)	2006-08-17	Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY138156A (en)	2009-04-30	Carbamate compounds for use in preventing or treating neurodegenerative disorders
YU68003A (sh)	2006-08-17	Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
IL157590A0 (en)	2004-03-28	Carbamate compounds for use in preventing or treating bipolar disorder
IL154052A0 (en)	2003-07-31	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
IL157594A0 (en)	2004-03-28	Carbamate compounds for use in preventing or treating anxiety disorders
PL368112A1 (pl)	2005-03-21	Związki karbaminianowe do stosowania w zapobieganiu lub leczeniu bólu neuropatycznego i bólu związanego z bólem głowy i migreną
IL159847A0 (en)	2004-06-20	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en)	2009-01-30	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136347A (en)	2008-09-30	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136733A (en)	2008-11-28	Carbamate compounds for use in preventing or treating psychotic disorders